Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study

Introduction: In addition to lipid-lowering effects, statins might modulate the gut microbiome and alleviate systematic inflammation, which in turn, may have a protective effect against irritable bowel syndrome (IBS). The aim of our study was to evaluate the gender-specific association between stati...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Xiaoying Zhang, Yuyao Liu, Yanghui Ou, Man Yang, Jinqiu Yuan, Qiangsheng He, Yanfei Li, Ningning Mi, Peng Xie, Wenjing Li, Siqin Wu, Xiwen Qin, Jian Qi, Bin Xia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Subjects:	irritable bowel syndrome statins (3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors) cohort study [or longitudinal study] protective factor United Kingdom Biobank
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1044542/full